Department of Cardiology, Central Hospital of Qinghe County, Xingtai, Hebei, China.
Department of Medical Education, Central Hospital of Qinghe County, Xingtai, Hebei, China.
Technol Health Care. 2024;32(6):4475-4484. doi: 10.3233/THC-240621.
In 2019, approximately 330 million individuals in China were affected by cardiovascular diseases, with 11.4 million cases specifically attributed to coronary artery disease (CAD). A national public health report indicated that the mortality rate for CAD ranged from 121.59 to 130.14 per 100,000 individuals in 2019. The treatments for CAD include lifestyle changes, medications, percutaneous coronary intervention (PCI) and coronary artery bypass grafting.
To investigate the management effect of a digital health program in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI).
This retrospective study compares blood pressure, blood glucose, low-density lipoprotein cholesterol (LDL-C), medication adherence, lifestyle modification, and readmission rate between digital health users and traditional follow-up in post-PCI CAD patients.
In this study of 698 CAD patients, the 6-month readmission rate of all patients was 27.4%, with digital health users showing lower rates than those in traditional follow-up (22.6% vs. 32.1%, p= 0.005). Digital health users had significantly higher target achievements rates in blood pressure (79.7% vs. 54.7%, p< 0.001), blood glucose (98.9% vs. 82.5%, p< 0.001) and LDL-C level (71.3% vs. 52.7%, p< 0.001) at 6-month post-PCI. The digital health group had more patients adopting lifestyle changes, including quitting smoking, maintaining a healthy diet, and exercising regularly. In risk factor analysis, digital health utilization (OR = 0.60, 95%CI: 0.40-0.90, p= 0.014) and multivessel disease (double: OR = 1.72, 95%CI: 1.09-2.72, p= 0.02; triple: OR = 2.59, 95%CI: 1.61-4.17, p< 0.001) were independent predictors of CAD-related cardiovascular readmissions.
Post-PCI patients using digital health platforms exhibited improved blood pressure, glucose, and LDL-C control, greater treatment adherence, enhanced lifestyle changes, and reduced six-month readmission rates versus those with traditional follow-up.
2019 年，中国约有 3.3 亿人受到心血管疾病的影响，其中 1140 万人患有冠心病（CAD）。一份国家公共卫生报告显示，2019 年 CAD 的死亡率为每 10 万人 121.59-130.14 人。CAD 的治疗包括生活方式改变、药物治疗、经皮冠状动脉介入治疗（PCI）和冠状动脉旁路移植术。
探讨数字健康计划在经皮冠状动脉介入治疗（PCI）后冠心病（CAD）患者管理中的效果。
本回顾性研究比较了数字健康使用者和传统随访者在 PCI 后 CAD 患者的血压、血糖、低密度脂蛋白胆固醇（LDL-C）、药物依从性、生活方式改变和再入院率。
本研究共纳入 698 例 CAD 患者，所有患者的 6 个月再入院率为 27.4%，数字健康使用者的再入院率低于传统随访者（22.6% vs. 32.1%，p=0.005）。数字健康使用者在 6 个月 PCI 后血压（79.7% vs. 54.7%，p<0.001）、血糖（98.9% vs. 82.5%，p<0.001）和 LDL-C 水平（71.3% vs. 52.7%，p<0.001）的达标率明显更高。数字健康组有更多患者采用生活方式改变，包括戒烟、保持健康饮食和定期锻炼。在危险因素分析中，数字健康的使用（OR=0.60，95%CI：0.40-0.90，p=0.014）和多支血管疾病（双支：OR=1.72，95%CI：1.09-2.72，p=0.02；三支：OR=2.59，95%CI：1.61-4.17，p<0.001）是 CAD 相关心血管再入院的独立预测因素。
与传统随访相比，使用数字健康平台的 PCI 后患者血压、血糖和 LDL-C 控制更理想，治疗依从性更高，生活方式改变更多，6 个月再入院率更低。
